BRONCHOPULMONARY DYSLASIA OF NEWBORNS AND PROSPECTS OF CELL THERAPY IN UKRAINE AND WORLDWIDE
Introduction. Premature birth is a serious challenge for modern medicine – in the world, about 14.9 million babies are born before 37 weeks of pregnancy, which is approximately 11.0% of all newborns. Bronchopulmonary dysplasia (BLD) is the most common form of chronic lung disease that affects premat...
Main Authors: | Illia V. Koshurba, Fedir V. Hladkykh, Yurii V. Koshurba |
---|---|
Format: | Article |
Language: | English |
Published: |
State Institution of Science «Research and Practical Center of Preventive and Clinical Medicine» State Administrative Department
2023-11-01
|
Series: | Клінічна та профілактична медицина |
Subjects: | |
Online Access: | https://cp-medical.com/index.php/journal/article/view/319 |
Similar Items
-
Early gestational mesenchymal stem cell secretome attenuates experimental bronchopulmonary dysplasia in part via exosome-associated factor TSG-6
by: Sushma Chaubey, et al.
Published: (2018-06-01) -
PREDICTIVE CAPABILITY OF NEUROTRACTOGRAPHY IN PREMATURE NEWBORNS WITH LOW AND EXTREMELY LOW BODY WEIGHT WITH MANIFESTING BRONCHOPULMONARY DYSPLASIA
by: M. P. Yakovenko, et al.
Published: (2017-10-01) -
PROGNOSTIC AND DIAGNOSTIC SIGNIFICANCE OF THE CLARA CELL PROTEIN LEVEL IN BRONCHOPULMONARY DYSPLASIA IN PRETERM NEWBORNS
by: Zhuravleva L. N., et al.
Published: (2020-06-01) -
Headway and the remaining hurdles of mesenchymal stem cells therapy for bronchopulmonary dysplasia
by: Eireen Tang, et al.
Published: (2022-10-01) -
MESENCHYMAL STEM CELLS: EXOSOMES AND CONDITIONED MEDIA AS INNOVATIVE STRATEGIES IN THE TREATMENT OF PATIENTS WITH AUTOIMMUNE DISEASES
by: Fedir V. Hladkykh
Published: (2023-12-01)